Kindred Biosciences reported -8544000 in Operating Profit for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Adma Biologics ADMA:US $ -14.44M 1.14M
Bayer BAYN:GR 530M 2.81B
Biocryst Pharmaceuticals BCRX:US $ -44.58M 15M
Dynavax Technologies DVAX:US $ 16.07M 12.13M
Eli Lilly And LLY:US $ 1476M 72.6M
Idexx Laboratories IDXX:US $ 225.96M 33.29M
JAZZ PHA JAZZ:US $ 28.37M 97.96M
Kindred Biosciences KIN:US -8544000 622K
Merk MRK:US $ 4826M 3212M
Minerva Neurosciences NERV:US $ -7.52M 1.44M
Novavax NVAX:US $ -307.14M 38.68M
Phibro Animal Health PAHC:US $ 14.61M 4.55M
Zoetis ZTS:US $ 659M 23M